SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
- Your Subscription
medcases00 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
153 views 1324 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
226 views 1326 days ago -
Watch Later
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
233 views 1285 days ago -
Watch Later
51:21"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
262 views 1306 days ago -
Watch Later
58:12"Updates in IgA Nephropathy" presented by Natalie Beck, MD
289 views 1306 days ago -
Watch Later
37:35"Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell
254 views 1306 days ago